keyword
https://read.qxmd.com/read/38612779/molecular-targets-of-novel-therapeutics-for-diabetic-kidney-disease-a-new-era-of-nephroprotection
#21
REVIEW
Alessio Mazzieri, Francesca Porcellati, Francesca Timio, Gianpaolo Reboldi
Diabetic kidney disease (DKD) is a chronic microvascular complication in patients with diabetes mellitus (DM) and the leading cause of end-stage kidney disease (ESKD). Although glomerulosclerosis, tubular injury and interstitial fibrosis are typical damages of DKD, the interplay of different processes (metabolic factors, oxidative stress, inflammatory pathway, fibrotic signaling, and hemodynamic mechanisms) appears to drive the onset and progression of DKD. A growing understanding of the pathogenetic mechanisms, and the development of new therapeutics, is opening the way for a new era of nephroprotection based on precision-medicine approaches...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38610694/new-onset-diabetes-mellitus-after-kidney-transplantation
#22
REVIEW
Salah Alajous, Pooja Budhiraja
New-Onset Diabetes Mellitus after Transplantation (NODAT) emerges as a prevalent complication post-kidney transplantation, with its incidence influenced by variations in NODAT definitions and follow-up periods. The condition's pathophysiology is marked by impaired insulin sensitivity and β-cell dysfunction. Significant risk factors encompass age, gender, obesity, and genetics, among others, with the use of post-transplant immunosuppressants intensifying the condition. NODAT's significant impact on patient survival and graft durability underscores the need for its prevention, early detection, and treatment...
March 27, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38607629/depression-onset-after-a-spouse-s-cardiovascular-event
#23
JOURNAL ARTICLE
Toshiaki Komura, Yusuke Tsugawa, Naoki Kondo, Kosuke Inoue
IMPORTANCE: Although cardiovascular disease (CVD) is a known risk factor for depression, evidence is lacking regarding whether and to what extent a spouse's CVD is associated with the subsequent mental health of individuals. OBJECTIVE: To examine the association between CVD onset in spouses and subsequent depression. DESIGN, SETTING, AND PARTICIPANTS: This cohort study examined 277 142 matched married couples enrolled in the Japan Health Insurance Association health insurance program between April 2015 and March 2022, covering approximately 40% of the working-age population in Japan...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38606682/thiazides-for-kidney-stone-recurrence-prevention
#24
JOURNAL ARTICLE
Matteo Bargagli, Sven Trelle, Olivier Bonny, Daniel G Fuster
PURPOSE OF REVIEW: Kidney stones are the most common condition affecting the kidney, and characterized by a high rate of recurrence. Thiazide and thiazide-like diuretics (thiazides) are commonly prescribed to prevent the recurrence of kidney stones. This review offers a comprehensive up-to-date assessment of the evidence supporting the use of thiazides for kidney stone recurrence prevention, highlights potential harms associated with treatment, and identifies areas of knowledge that require further investigation...
April 11, 2024: Current Opinion in Nephrology and Hypertension
https://read.qxmd.com/read/38606021/the-development-of-diabetes-and-diabetic-ketoacidosis-following-immunotherapy-treatment-a-systematic-review-of-case-reports
#25
REVIEW
Stephanie Nagy, Michelle Demory Beckler, Atif Hussein, Marc M Kesselman
As cancer continues to be the leading cause of death worldwide, additional therapeutic options other than traditional platinum-based chemotherapy have become available that target tumor cells in innovative ways. Immunotherapies (e.g., immune checkpoint inhibitors (ICI)) ramp up the immune system to target cancer cells, providing patients with more personalized and tumor cell-specific treatment options. This new age oncological treatment option has been found to provide a more meaningful and stronger alternative to traditional chemotherapy, resulting in longer periods of remission and milder side effects...
April 2024: Curēus
https://read.qxmd.com/read/38600574/factors-influencing-hospitalization-or-emergency-department-visits-and-mortality-in-type-2-diabetes-following-the-onset-of-new-cardiovascular-diagnoses-in-a-population-based-study
#26
JOURNAL ARTICLE
Björn Agvall, Junmei Miao Jonasson, Alexander Galozy, Anders Halling
BACKGROUND: Individuals with type 2 diabetes (T2D) are at increased risk of developing cardiovascular disease (CVD) which necessitates monitoring of risk factors and appropriate pharmacotherapy. This study aimed to identify factors predicting emergency department visits, hospitalizations, and mortality among T2D patients after being newly diagnosed with CVD. METHODS: In a retrospective observational study conducted in Region Halland, individuals aged > 40 years with T2D diagnosed between 2011 and 2019, and a new diagnosis of CVD between 2016 and 2019, were followed for one year from the date of CVD diagnosis...
April 10, 2024: Cardiovascular Diabetology
https://read.qxmd.com/read/38598368/the-added-value-of-blood-glucose-monitoring-in-high-risk-individuals-undergoing-pancreatic-cancer-surveillance
#27
JOURNAL ARTICLE
Aleksander M Bogdanski, Anke M Onnekink, Akin Inderson, Bas Boekestijn, Bert A Bonsing, Hans F A Vasen, Jeanin E van Hooft, Jurjen J Boonstra, J Sven D Mieog, Martin N J M Wasser, Shirin Feshtali, Thomas P Potjer, Derk C F Klatte, Monique E van Leerdam
OBJECTIVES: The study aimed to investigate the added value of blood glucose monitoring in high-risk individuals (HRIs) participating in pancreatic cancer surveillance. METHODS: HRIs with a CDKN2A/p16 germline pathogenic variant (PV) participating in pancreatic cancer surveillance were included in this study. Multivariable logistic regression was performed to assess the relationship between new-onset diabetes (NOD) and pancreatic ductal adenocarcinoma (PDAC). To quantify the diagnostic performance of NOD as a marker for PDAC, receiver operating characteristic curve with area under the curve (AUC) was computed...
April 10, 2024: Pancreas
https://read.qxmd.com/read/38597850/diabetic-ketoacidosis-in-type-1-diabetes-onset-in-latin-american-children
#28
JOURNAL ARTICLE
Valeria Hirschler, Claudio D Gonzalez, Gabriela Krochik, Adriana M Rousos, Maria E Andres, Francisca Riera, Paola Pinto Ibarcena, Claudia Molinari, Luis F Palacios Porta, Mariana Prieto, Carolina Martinez Mateu, Consuelo Barcala, Maria A Arrigo, Jacqueline Tachetti, Marcela Raggio, Veronica Vacarezza, Maria L Major, Angela Figueroa Sobrero, Ernesto Bogado, Stella Lopez, Paula Paz Povedano, Edit Scaiola, Fabiana Leiva, Gabriela Pacheco, Patricia Pasayo, Mariana Dupuy, Maria B Torossi, Amanda J Benitez, Andrea Escalante Marassi, Zulema Caballero, Ana L Garcia, Sandra Mazzetti, Maria I Ruiz Pugliese, Diana S Gonzalez, Florencia Grabois, Carlos M Del Aguila Villar, Adriana B Flores
OBJECTIVE: To describe the patterns of diabetic ketoacidosis (DKA) occurrence in children newly diagnosed with type 1 diabetes (T1DM) across several Latin American pediatric diabetes centers from 2018 to 2022. METHODS: A retrospective chart review included children under 18 with new-onset T1DM from 30 Latin American pediatric diabetes centers (Argentina, Chile, and Peru) between 30 December 2018 and 30 December 2022. Multiple logistic regression models examined the relationships between age, gender, medical insurance, BMI, and DKA at new-onset T1DM...
April 10, 2024: Journal of Pediatric Health Care
https://read.qxmd.com/read/38597588/emergence-of-de-novo-conditions-following-remission-of-cushing-syndrome-a-case-report-and-scoping-review
#29
REVIEW
Noémie Desgagnés, Laura Senior, Daniel Vis, Katayoun Alikhani, Kirstie Lithgow
OBJECTIVE: Onset and exacerbation of autoimmune, inflammatory or steroid-responsive conditions have been reported following the remission of Cushing syndrome, leading to challenges in distinguishing a new condition versus expected symptomatology following remission. We describe a case of a 42-year-old man presenting with new-onset sarcoidosis diagnosed 12 months following the surgical cure of Cushing syndrome and synthesise existing literature reporting on de novo conditions presenting after Cushing syndrome remission...
May 2024: Endocrinology, Diabetes & Metabolism
https://read.qxmd.com/read/38595695/glucometabolic-related-genes-as-diagnostic-biomarkers-and-therapeutic-targets-for-alzheimer-s-disease-and-type-2-diabetes-mellitus-a-bioinformatics-analysis
#30
JOURNAL ARTICLE
Shuo Liu, He Chen, Xiao-Dong He, Xiao-Ou Yang
BACKGROUND: Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are two widespread chronic disorders characterized by shared risk factors and molecular pathways. Glucose metabolism, pivotal for cellular homeostasis and energy supply, plays a critical role in these diseases. Its disturbance has been linked to the pathogenesis of both AD and T2DM. However, a comprehensive investigation into the specific roles of glucometabolic genes in the onset and progression of AD and T2DM has yet to be conducted...
2024: Neurology Research International
https://read.qxmd.com/read/38594674/proteomic-studies-of-vegfr2-in%C3%A2-human-placentas-reveal-protein-associations%C3%A2-with-preeclampsia-diabetes-gravidity-and-labor
#31
JOURNAL ARTICLE
Shannon J Ho, Dale Chaput, Rachel G Sinkey, Amanda H Garces, Erika P New, Maja Okuka, Peng Sang, Sefa Arlier, Nihan Semerci, Thora S Steffensen, Thomas J Rutherford, Angel E Alsina, Jianfeng Cai, Matthew L Anderson, Ronald R Magness, Vladimir N Uversky, Derek A T Cummings, John C M Tsibris
VEGFR2 (Vascular endothelial growth factor receptor 2) is a central regulator of placental angiogenesis. The study of the VEGFR2 proteome of chorionic villi at term revealed its partners MDMX (Double minute 4 protein) and PICALM (Phosphatidylinositol-binding clathrin assembly protein). Subsequently, the oxytocin receptor (OT-R) and vasopressin V1aR receptor were detected in MDMX and PICALM immunoprecipitations. Immunogold electron microscopy showed VEGFR2 on endothelial cell (EC) nuclei, mitochondria, and Hofbauer cells (HC), tissue-resident macrophages of the placenta...
April 9, 2024: Cell Communication and Signaling: CCS
https://read.qxmd.com/read/38594474/mafld-as-part-of-systemic-metabolic-dysregulation
#32
JOURNAL ARTICLE
Jing Zhao, Lu Liu, Ying-Ying Cao, Xin Gao, Giovanni Targher, Christopher D Byrne, Dan-Qin Sun, Ming-Hua Zheng
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. In recent years, a new terminology and definition of metabolic dysfunction-associated fatty liver disease (MAFLD) has been proposed. Compared to the NAFLD definition, MAFLD better emphasizes the pathogenic role of metabolic dysfunction in the development and progression of this highly prevalent condition. Metabolic disorders, including overweight/obesity, type 2 diabetes mellitus (T2DM), atherogenic dyslipidemia and hypertension, are often associated with systemic organ dysfunctions, thereby suggesting that multiple organ damage can occur in MAFLD...
April 9, 2024: Hepatology International
https://read.qxmd.com/read/38594224/express-association-of-statins-with-onset-and-progression-of-non-alcoholic-fatty-liver-disease-in-patients-with-diabetes
#33
JOURNAL ARTICLE
Raj Shah, Alexander Kong Ibanez, Silvio W De Melo, Moheb Boktor, Richard Henriquez, Amar Mandalia, Hrishikesh Samant, Carlos Alvarez, Ishak Mansi
Non-alcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease in patients with diabetes; limited data suggested that statins may reduce the risk of NAFLD progression. This study aimed to examine the association between statins and the development or progression of NAFLD in veterans with diabetes. In a new-user negative control design, we conducted a retrospective propensity-score (PS) matched cohort study of patients with diabetes between 2003 and 2015. After excluding patients with other causes of liver disease, we formed PS using 85 characteristics...
April 9, 2024: Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research
https://read.qxmd.com/read/38594149/identification-influencing-factors-and-outcomes-of-time-delays-in-the-management-pathway-of-diabetic-foot-a-systematic-review
#34
REVIEW
Li Lingyan, Xu Liwei, Zhao Han, Tang Xin, He Bingyang, Ma Yuanyuan, Qin Peiwei, Ma Peifen
OBJECTIVE: A systematic review was conducted to evaluate the time delays in the management of diabetic foot and explore influencing factors of these delays and potential outcomes. METHODS: The researchers searched several electronic databases (Pubmed, Web of Science, Cochrane Library, EMbase, CNKI, WanFang, CBM and VIP) for English and Chinese studies that examined time delays in the management pathway of diabetic foot. Two authors independently screened and extracted data, and assessed the quality of the included studies using the Newcastle-Ottawa Scale and the Agency for Health Research and Quality checklist...
April 5, 2024: Journal of Tissue Viability
https://read.qxmd.com/read/38593410/the-association-between-the-triglyceride-to-high-density-lipoprotein-cholesterol-ratio-and-the-incidence-of-type-2-diabetes-mellitus-in-the-japanese-population
#35
JOURNAL ARTICLE
Guojuan Xu, Jing Song
Abstract Aims: To explore whether the triglyceride to high-density lipoprotein cholesterol ratio (TG/HDL-C) was independently associated with the risk of incident type 2 diabetes mellitus (T2DM) in a large Japanese cohort. Methods: A secondary analysis was performed using open-access data from a retrospective cohort study. A total of 12,716 eligible participants who had standard medical examinations at the Murakami Memorial Hospital were included in this study. New-onset T2DM was the main outcome during follow-up...
April 8, 2024: Metabolic Syndrome and related Disorders
https://read.qxmd.com/read/38593305/a-new-insight-into-fatty-acid-binding-protein-4-mechanisms-and-therapeutic-implications-in-obesity-associated-diseases-a-mini-review
#36
REVIEW
Feyza Nur Başarır Sivri, Seda Çiftçi
Fatty acid binding proteins (FABPs), such as FABP4 (aP2, A-FABP), are essential for cellular lipid regulation, membrane-protein interactions, and the modulation of metabolic and inflammatory pathways. FABP4, primarily expressed in adipocytes, monocytes, and macrophages, is integrated into signaling networks that influence immune responses and insulin activity. It has been linked to obesity, inflammation, lipid metabolism, insulin resistance, diabetes, cardiovascular disease, and cancer. Inhibition of FABP4 is emerging as a promising strategy for treating obesity-related conditions, particularly insulin resistance and diabetes...
April 9, 2024: Molecular Nutrition & Food Research
https://read.qxmd.com/read/38590324/covid-19-infection-and-incident-diabetes-in-american-indian-and-alaska-native-people-a-retrospective-cohort-study
#37
JOURNAL ARTICLE
James W Keck, Mary E Lacy, Sara Bressler, Ian Blake, Uzo Chukwuma, Michael G Bruce
BACKGROUND: Evidence suggests an increased risk of new-onset diabetes following COVID-19 infection. American Indian/Alaska Native (AI/AN) people were disparately impacted by the COVID-19 pandemic and historically have had higher diabetes incidence than other racial/ethnic groups in the US. We measured the association between COVID-19 infection and incident diabetes in AI/AN people. METHODS: We conducted a retrospective cohort study using de-identified patient data from the Indian Health Service's (IHS) National Patient Information Reporting System...
May 2024: Lancet Reg Health Am
https://read.qxmd.com/read/38590308/artificial-intelligence-powered-glucose-monitoring-and-controlling-system-pumping-module
#38
JOURNAL ARTICLE
Sravani Medanki, Nikhil Dommati, Hema Harshitha Bodapati, Venkata Naga Sai Kowsik Katru, Gollapalli Moses, Abhishek Komaraju, Nanda Sai Donepudi, Dhanya Yalamanchili, Jasti Sateesh, Pratap Turimerla
BACKGROUND: Diabetes, a globally escalating health concern, necessitates innovative solutions for efficient detection and management. Blood glucose control is an essential aspect of managing diabetes and finding the most effective ways to control it. The latest findings suggest that a basal insulin administration rate and a single, high-concentration injection before a meal may not be sufficient to maintain healthy blood glucose levels. While the basal insulin rate treatment can stabilize blood glucose levels over the long term, it may not be enough to bring the levels below the post-meal limit after 60 min...
March 20, 2024: World Journal of Experimental Medicine
https://read.qxmd.com/read/38586590/clinical-outcomes-following-discontinuation-of-metformin-in-patients-with-type-2-diabetes-and-advanced-chronic-kidney-disease-in-hong-kong-a-territory-wide-retrospective-cohort-and-target-trial-emulation-study
#39
JOURNAL ARTICLE
Aimin Yang, Mai Shi, Hongjiang Wu, Eric Sh Lau, Johnny Tk Cheung, Xinge Zhang, Baoqi Fan, Tingting Chen, Alice Ps Kong, Andrea Oy Luk, Ronald Cw Ma, Juliana Cn Chan, Elaine Chow
BACKGROUND: Current labelling advises discontinuation of metformin when estimated glomerular filtration rate (eGFR) < 30 ml/min/1.73 m2 due to increased risk of lactic acidosis. However, in real-world practice, the risk-benefit ratios remain uncertain. We examined the risk associations of discontinued-metformin use with cardiorenal and clinical outcomes in patients with type 2 diabetes (T2D) and advanced chronic kidney disease. METHODS: In this territory-wide, retrospective cohort and target trial emulation study, we included Chinese patients attending the Hong Kong Hospital Authority (HA) and enrolled in the Risk-Assessment-and-Management-Programme-for-Diabetes-Mellitus (RAMP-DM) from 2002 to 2019...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38584567/prediction-of-new-onset-heart-failure-in-patients-with-type-2-diabetes-derived-from-altitude-and-canvas
#40
JOURNAL ARTICLE
Fatema Said, Clare Arnott, Adriaan A Voors, Hiddo J L Heerspink, Jozine M Ter Maaten
AIM: To create and validate a prediction model to identify patients with type 2 diabetes (T2D) at high risk of new-onset heart failure (HF), including those treated with a sodium-glucose cotransporter-2 (SGLT2) inhibitor. METHODS: A prediction model was developed from the Aliskiren Trial in Type 2 Diabetes Using Cardiorenal Endpoints (ALTITUDE), a trial in T2D patients with albuminuria or cardiovascular disease. We included 5081 patients with baseline N-terminal pro B-type natriuretic peptide (NT-proBNP) measurement and no history of HF...
April 8, 2024: Diabetes, Obesity & Metabolism
keyword
keyword
57187
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.